Friday, 16 October 2026European Markets

ALSTOM Stock Jump On Monday, Outperforms Market

Loading stream...

(vianews) - the market ended the session with alstom (alo.pa) rising 9.34% to €13.46 on monday while cac 40 slid 0.2% to €8,148.14.

alstom's last close was €12.31, 56.67% under its 52-week high of €28.41.

about alstom

alstom sa offers solutions for rail transport industry in europe, the americas, asia and pacific, the middle east, central asia, and africa. the company offers rolling stock solutions comprising people movers and monorails, light rails, metros, commuter trains, regional and intercity trains, high-speed trains, and locomotives; asset optimization, cybersecurity, connectivity, digital passenger, and security and city mobility solutions; and signaling products, such as urban, mainline, and freight and mining signaling. it also provides apm, monorail, tram, metro, and main line systems; and tracklaying and track solutions, catenary free and ground feeding solutions, electrification solutions, and electromechanical equipment., as well as cybersecurity solutions. in addition, the company provides maintenance, modernization, parts and repair, and support services. further, it offers various components, including bogies, motors and generators, switchgears, auxiliary converters, traction transformers, brake friction, components propulsion, train control and information systems, hydrogen and battery solutions, and dispen dampers. the company was founded in 1928 and is based in saint-ouen, france.

earnings per share

as for profitability, alstom has a trailing twelve months eps of €-0.29.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -0.93%.

yearly top and bottom value

alstom's stock is valued at €13.46 at 21:30 est, way below its 52-week high of €28.41 and way above its 52-week low of €10.68.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, alstom's stock is considered to be oversold (<=20).

more news about alstom (alo.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com